Navigation Links
Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients With Relapsed Solid Tumors
Date:5/1/2008

and a selective immunoproteasome inhibitor. For additional information on Proteolix, please visit http://www.proteolix.com.

Contact information

Matthew Ferguson

investors@proteolix.com

650-266-2825


'/>"/>
SOURCE Proteolix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
3. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
8. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
9. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. Prolexys Pharmaceuticals Initiates Phase 1 Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Nov. 20 In response to ...hy currently available medications designed to tre...I Institute, an independent nonprofit organization...eride for Prevention of Prostate Cancer for free... Times article, " Drugs to Deter Some Cancers Are...
(Date:11/19/2009)...9 BioCryst Pharmaceutica...ing of a public offering of 5,000,000 shares of it...oss proceeds of $48.75 million. All of the shares...ctive shelf registration statement previously file...oCryst has also granted the underwriters a 30-day ...
(Date:11/19/2009)...wswire/ -- Riverain Medical announced today that t...n medical imaging distributor Christie Group to of...est Xray CAD. The exclusive agreement will bring D...he Canadian market through Christie Group,s establ...Enhanced Chest Imaging increases the clarity of di...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 1Scholarships Available for PA Breast Cancer Coalition Annual Conference 52115 2Announcing the Launch of Chemo Couture com 52111 1Derma Sciences Inc Hires the Investor Relations Group 13090 1Derma Sciences Inc Hires the Investor Relations Group 13090 2Derma Sciences Inc Hires the Investor Relations Group 13090 3
...ociation for Cancer Research meeting indicate tha...on of non-water-soluble drugs to treat cancer and...16 Celator Pharmaceuticals today,reported results...t are,incapable of dissolving in water (hydrophobi...rug circulation. These findings allow the company ...
... A new Mayo,Clinic study found that regular physic...e impairment, a disorder of the brain that affects...study will be presented at the,American Academy of... Individuals with mild cognitive impairment can f...t often have difficulty remembering details of,con...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2
(Date:11/22/2009)...v. 21 Congressman Chaka... the United States Senate,s vote tonight to procee... ,, "Senators Arlen Specter and Bob Casey deser...ians for casting stand-up, critical votes in the S... Affordable Health Care Reform legislation to full...
(Date:11/21/2009)... Nov. 21 A regional ini...rciasis (river blindness) in the Americas has subs... recent years, as evidenced by a 31% decrease in t...istration in six endemic countries. Results were ...merican Society of Tropical Medicine and Hygiene (...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game, S... Touch. , Mountain View, ... popular and addictive game, SplitWords, is now av...is designed to help banish that ,tip of the tongue...ain game challenges the brain by encouraging user...
(Date:11/20/2009)...J, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharma...ting of Shareholders will be held on Monday, Decem...sider approval of two special resolutions. The fir...the sale of all or substantially all of the assets...or in the asset purchase agreement dated November ...
(Date:11/20/2009)....J., Nov. 20 Rates of in...peaked in late October, but the pandemic flu virus...all age groups, including the elderly, according t...NYSE: DGX ), the world,s leading provider of dia...In its most recent Quest Diagnostics Health Trends...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...IA Anyone can save a life. Thats the message from...ol of Medicine. , Benjamin S. Abella, MD, MPhil,...suscitation Science and Assistant Professor of Eme...ts that occur each year outside of hospitals in th...
...5 twice as likely to find either symptom fuels the...y News) -- Obesity and depression often go hand-in.... , The research collected information on the heig...aire used to measure depression symptoms. , Women ...
...y in the UK has improved significantly over the la... National Physical Laboratory (NPL). Monitoring at...e presence of harmful heavy metals such as lead, i...verage concentration has fallen from 1873 nanogram...
...., Jan. 14 Edwards Lifesciences,Corporation (NYSE...es to,treat advanced cardiovascular disease, annou...in assets related to the Edwards LifeStent,product...cular disease,treatments, is the number-one heart ...
... Calif., Jan. 14 Fusion Energy,Products, manufact... owned,subsidiary of Bond Laboratories, Inc. (OTC ...P owned am/pm convenience stores will be joining i.../pm have been ongoing sponsors of Supercross racin...
... Tenn.New research from Vanderbilt University show...ession as a reward - much like sex, food and drugs...and our fascination with violent sports like boxin...ll vertebrates and is necessary to get and keep im...
Other Medicine News:Health News:Anyone can save a life: Penn researchers lead national efforts to improve CPR quality 2Health News:Anyone can save a life: Penn researchers lead national efforts to improve CPR quality 3Health News:Depression, Obesity Coexist in Many Middle-Aged Women 2Health News:Heavy metal slips down UK air quality charts 2Health News:Fusion Energy Teams Up With BP's 'am/pm' Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution 2Health News:Aggression as rewarding as sex, food and drugs 2
Arrow HexaPolar EP Catheter
Inquiry Steerable Diagnostic Catheters
Envoy
Mayfield Triad Skull Clamp
Medicine Products: